Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells

  • Hal E. Broxmeyer
Part of the Cancer Treatment and Research book series (CTAR, volume 84)


All the circulating blood cell elements are produced by a set of primitive cells termed hematopoietic stem and progenitor cells. Each category is considered to be hierarchical in nature, with cells from the most immature to mature being produced in a catenated fashion. Conceptually, the earliest subset of cells would be the long-term marrow-repopulating stem cell (LTMRSC). This cell would be considered to have the greatest degree of self-renewal capacity and would be the cell type that one would like to make sure was in the tissue source of transplantable cells for long-term repopulation of the blood system of the recipient. It is also this cell that would be the one investigators would like to use in a gene therapy setting for long-term expression of newly integrated genetic material by gene transfer. While the LTMRSC is inferred from animal studies, particularly those studies in mice in which serial transplantation of marrow cells from mouse to mouse to repopulate the blood system is assessed, it is not clear yet whether there is a quantitative assay for this cell in the human system [1]. The LTMRSC gives rise to more mature cells within the stem cell compartment, which can be defined by more limited cell renewal capacity.


Cord Blood Umbilical Cord Blood Fanconi Anemia Cord Blood Transplant Human Umbilical Cord Blood 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Broxmeyer HE (1994). Consequences of human stem cells taking up residence in sheep. J Clin Invest 93:919.PubMedCrossRefGoogle Scholar
  2. 2.
    Broxmeyer HE (1993). Role of cytokines in hematopoiesis. In Oppenheim JJ, Rossio JL, Gearing AJH (eds), Clinical Aspects of Cytokines. Role in Pathogenesis, Diagnosis and Therapy. Oxford University Press: New York, 201–206.Google Scholar
  3. 3.
    Carow C, Hangoc G, Broxmeyer HE (1993). Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 81:942–949.PubMedGoogle Scholar
  4. 4.
    Zanjani ED, Flake AW, Rich H, Hedrick M, Tavassoli M (1994). Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 93:1051–1055.PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas ED (1991). Frontiers in bone marrow transplantation. Blood Cells 17:259–267.PubMedGoogle Scholar
  6. 6.
    Lu L, Shen RN, Broxmeyer HE (in press). Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Crit Rev Oncol/Hematol.Google Scholar
  7. 7.
    Goldman J (1995). Peripheral blood stem cells for allografting. Blood 85:1413–1415.PubMedGoogle Scholar
  8. 8.
    Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD (1995). Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655–1658.PubMedGoogle Scholar
  9. 9.
    Korbling M, Przepiorka D, Huh YO, Engel H, Van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R (1995). Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659–1665.PubMedGoogle Scholar
  10. 10.
    Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH (1995). Primary transplantation of allogeneic peripheral blood progenitor cells by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666–1672.PubMedGoogle Scholar
  11. 11.
    Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Amy M, Thomas L, Boyse EA (1989). Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828–3832.PubMedCrossRefGoogle Scholar
  12. 12.
    Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, Broun ER (1992). Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109–4113.PubMedCrossRefGoogle Scholar
  13. 13.
    Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA (1989). Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178.PubMedCrossRefGoogle Scholar
  14. 14.
    Hows JM, Bradley BA, Marsh JCW, Luft T, Coutinho L, Testa NG, Dexter TM (1992). Growth of human umbilical-cord blood in long term haematopoietic cultures. Lancet 340:73–76.PubMedCrossRefGoogle Scholar
  15. 15.
    Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJV, Zsebo KM, Adamson JW (1992). Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620–2627.PubMedGoogle Scholar
  16. 16.
    Lu L, Xiao M, Shen RN, Grigsby S, Broxmeyer HE (1992). Enrichment, characterization, and responsiveness of single primitive CD34+++ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41–48.Google Scholar
  17. 17.
    Lansdorp PM, Dragowska W, Mayani H (1993). Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787–791.PubMedCrossRefGoogle Scholar
  18. 18.
    Cardoso AA, Li ML, Batard P, Hatzfeld A, Brown EL, Levesque JP, Sookdeo H, Panterne B, Sansilvestri P, Clark SC, Hatzfeld J (1993). Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 90:8707–8711.PubMedCrossRefGoogle Scholar
  19. 19.
    Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S, Falkenburg JHF, Bard J, Boyse EA (1991). Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 17:313–329.PubMedGoogle Scholar
  20. 20.
    Kohli-Kumar M, Shahidi NT, Broxmeyer HE, Masterson M, Delaat C, Sambrano J, Morris C, Auerbach AD, Harris RE (1993). Haematopoietic stem/progenitor cell transplant in Fanconi anaemia using HLA-matched sibling umbilical cord blood cells. Br J Haematol 85:419–422.PubMedCrossRefGoogle Scholar
  21. 21.
    Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N, Griffin C, Emanuel PD, Zuckerman KS, Cooper S, Carow C, Bias W, Santos GW (1992). Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood 79:1874–1881.PubMedGoogle Scholar
  22. 22.
    Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E (1995). Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease. Lancet 346:214–219.PubMedCrossRefGoogle Scholar
  23. 23.
    Risdon G, Gaddy J, Stehman FB, Broxmeyer HE (1994). Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 154:14–24.PubMedCrossRefGoogle Scholar
  24. 24.
    Risdon G, Gaddy J, Broxmeyer HE (1994). Allogeneic responses of human umbilical cord blood. Blood Cells 20:566–572.PubMedGoogle Scholar
  25. 25.
    Risdon G, Gaddy J, Horie M, Broxmeyer HE (1995). Alloantigen priming induces a state of unresponsiveness in human cord blood T cells. Proc Natl Acad Sci USA 92:2413–2417.PubMedCrossRefGoogle Scholar
  26. 26.
    Gaddy J, Risdon G, Broxmeyer HE (1995). Cord blood natural killer cells are functionally and phenotypically immature but readily respond to IL-2 and IL-12. J Interferon Cytokine Res 15:527–536.PubMedCrossRefGoogle Scholar
  27. 27.
    Berthou C, Legros-Maida S, Soulie A, Wargnier A, Guillet J, Rabian C, Gluckman E, Sasportes M (1995). Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 85:1540–1546.PubMedGoogle Scholar
  28. 28.
    Gluckman E, Wagner J, Hows J, Kernan N, Bradley B, Broxmeyer HE (1993). Cord blood banking for hematopoietic stem cell transplantation: an international cord blood transplant registry. Bone Marrow Transpl 11:199–200.Google Scholar
  29. 29.
    Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE (1993). Stored placental blood for unrelated bone marrow reconstitution. Blood 81:1679–1690.PubMedGoogle Scholar
  30. 30.
    Rubinstein P, Taylor PE, Scaradavou A, Adamson JW, Migliaccio G, Emanuel D, Berkowitz RL, Alvarez E, Stevens CE (1994). Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells 20:587–600.PubMedGoogle Scholar
  31. 31.
    Gluckman E (1994). European organisation for cord blood banking. Blood Cells 20:601–608.PubMedGoogle Scholar
  32. 32.
    McCullough J, Clay ME, Fautsch S, Noreen H, Segall M, Perry E, Stroncek D (1994). Proposed policies and procedures for the establishment of a cord blood bank. Blood Cells 20:609–626.PubMedGoogle Scholar
  33. 33.
    Van Rood JJ (1994). Commentary: cord blood banking for bone marrow reconstitution: a need for standardization and international cooperation. Blood Cells 20:627–629.PubMedGoogle Scholar
  34. 34.
    Bogdanic V, Nemet D, Kastelan A, Latin V, Petrovecki M, Brkljacic-Surlakovic L, Kerhin-Brkjacic V, Aurer I, Konja J, Mrsic M, Kalenic S, Laber B (1992). Umbilical cord blood transplantation in a patient with Philadelphia chromosome-positive chronic myeloid leukemia. Transplantation 56:477–479.Google Scholar
  35. 35.
    Vowels MR, Lam-Po-Tang R, Berdoukas V, Ford D, Thierry D, Purtilo D, Gluckman E (1993). Brief report: correction of x-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 329:1623–1625.PubMedCrossRefGoogle Scholar
  36. 36.
    Vowels MR, Tiedemann K, Lam-Po-Tang R, Tucker DP (1994). Use of granulocyte-macrophage colony stimulating factor in two children treated with cord blood transplantation. Blood Cells 20:249–255.PubMedGoogle Scholar
  37. 37.
    Pahwa RN, Fleischer A, Than S, Good RA (1994). Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia. Proc Natl Acad Sci USA 91:4485–4488.PubMedCrossRefGoogle Scholar
  38. 38.
    Pahwa RN, Fleischer A, Shih S, Uckan D, Durham S, Garofalo P, Karayalcin G, Shende A, Redner A, Paley C, Good RA, Lanzkowsky P (1994). Erythrocyte-depleted allogeneic human umbilical cord blood transplantation. Blood Cells 20:267–274.PubMedGoogle Scholar
  39. 39.
    Kernan NA, Schroeder ML, Ciavarella D, Preti RA, Rubinstein P, O’Reilly RJ (1994). Umbilical cord blood infusion in a patient for correction of Wiskott Aldrich syndrome. Blood Cells 20:245–248.PubMedGoogle Scholar
  40. 40.
    Issaragrisil S (1994). Cord blood transplantation in thalassemia. Blood Cells 20:259–263.PubMedGoogle Scholar
  41. 4L.
    Kurtzberg J, Graham M, Casey J, Olsen J, Stevens C, Rubinstein P (1994). The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 20:275–284.PubMedGoogle Scholar
  42. 42.
    Vilmer E, Quelvennec E, Plouvier E, Denamur E, Rohrlich P, Elion J, Sterkers G (1994). HLA mismatched cord blood transplantation immunological studies. Blood Cells 20235–20241.Google Scholar
  43. 43.
    Vilmer E, Sterkers G, Rahimy C, Denamur E, Elion J, Broyart A, Lescoeur B, Tiercy JM, Gerota J, Blot P (1992). HLA mismatched cord blood transplantation in a patient with advanced leukemia. Transplantation 53:1128–1134.CrossRefGoogle Scholar
  44. 44.
    Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T, Kanokpongsakdi S, Siritararatkul N, Piankijagum A (1995). Transplantation of cord blood stem cells into a patient with severe thalassemia. N Engl J Med 332:367–369.PubMedCrossRefGoogle Scholar
  45. 45.
    Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hersfield MS, Mullen CA, Blaese RM, Parkman R (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine 10:1–7.CrossRefGoogle Scholar
  46. 46.
    Broxmeyer HE (1995). Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in transplantation. Transfusion 35:694–702.PubMedCrossRefGoogle Scholar
  47. 47.
    Lu L, Xiao M, Grigsby S, Wang WX, Wu B, Shen RN, Broxmeyer HE (1993). Comparative effects of suppressive cytokines on isolated single CD34+++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol 21:1442–1446.PubMedGoogle Scholar
  48. 48.
    Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF (1994). Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 22:215–222.PubMedGoogle Scholar
  49. 49.
    Moore MAS, Hoskins I (1994). Ex vivo expansion of cord blood derived stem cells and progenitors. Blood Cells 20:468–481.PubMedGoogle Scholar
  50. 50.
    Ruggieri L, Heimfeld S, Broxmeyer HE (1994). Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Blood Cells 20:436–454.PubMedGoogle Scholar
  51. 51.
    Xiao M, Broxmeyer HE, Horie M, Grigsby S, Lu L (1994). Extensive proliferative capacity of single isolated CD34+++ human cord blood cells in suspension culture. Blood Cells 20:455–467.PubMedGoogle Scholar
  52. 52.
    Van Zant G, Rummel SA, Koller MR, Larson DB, Drubachevsky I, Palsson M, Emerson SG (1994). Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells 20:482–491.PubMedGoogle Scholar
  53. 53.
    Heimfeld S, Kalamasz DF, Fogarty BL, Fei R, Tsui ZN, Jones HM, Berenson RJ (1994). Isolation and ex vivo expansion of CD34+ cells from cord blood using dextran sedimentation and avidin column selection. Blood Cells 20:397–403.PubMedGoogle Scholar
  54. 54.
    Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J (1994). Harvesting, characterization and culture of CD34+ cells from human bone marrow, peripheral blood and cord blood. Blood Cells 20:411–423.PubMedGoogle Scholar
  55. 55.
    Lebkowski JS, Schain L, Hall M, Wysocki M, Dadey B, Biddle W (1994). Rapid isolation and serum-free expansion of human CD34+ cells. Blood Cells 20:404–410.PubMedGoogle Scholar
  56. 56.
    Pettengell R, Luft T, Henschler R, Hows JM, Dexter TM, Ryder D, Testa NG (1994). Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84:3653–3659.PubMedGoogle Scholar
  57. 57.
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Hoffman R, Law P, Srour EF (1994). Human umbilical cord blood hematopoietic progenitor cells: are they are same as their adult bone marrow counterparts? Blood Cells 20:382–391.PubMedGoogle Scholar
  58. 58.
    Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD (1995). Flt3-ligand stimulates/ costimulates the growth of myeloid stem/progenitor cells. Exp Hematol 23:1121–1129.PubMedGoogle Scholar
  59. 59.
    Nimgaonkar MT, Roscoe RA, Persichetti J, Rybka WB, Winkelstein A, Ball ED (1995). A unique population of CD34+ cells in cord blood. Stem Cells 13:158–166.PubMedCrossRefGoogle Scholar
  60. 60.
    Bertolini F, Lazzari L, Lauri E, Corsini C, Sirchia G (1994). Cord blood plasma-mediated ex vivo expansion of hematopoietic progenitor cells. Bone Marrow Transplant 14:347–353.PubMedGoogle Scholar
  61. 61.
    Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE (1994). Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodedicient mice. Blood 83:2489–2497.PubMedGoogle Scholar
  62. 62.
    Orazi A, Braun SE, Broxmeyer HE (1994). Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models. Blood Cells 20:323–330.PubMedGoogle Scholar
  63. 62a.
    Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM (1995). Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 182:2037–2043.PubMedCrossRefGoogle Scholar
  64. 62b.
    Lu L, Ge Y, Li ZH, Keeble W, Kabat D, Bagby GC, Broxmeyer HE, Hoatlin ME (1996). Influence of retroviral-mediated gene transduction of recombinant human erythropoietin receptor gene into single hematopoietic stem/progenitor colls from human cord blood on the growth of these cells. Blood 87:525–534.PubMedGoogle Scholar
  65. 62c.
    Lu L, Li ZH, Xiao M, Broxmeyer HE (in press) Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34+++ CD33- or low cord blood cells on cytokine stimulated colony formation. Exp Hematol.Google Scholar
  66. 63.
    Moritz T, Keller DC, Williams DA (1993). Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529–536.PubMedCrossRefGoogle Scholar
  67. 64.
    Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE (1993). High efficiency retroviral ediated gene transduction into single isolated immature and replatable CD34+++ hematopoietic stem/ progenitor cells from human umbilical cord blood. J Exp Med 178:2089–2096.PubMedCrossRefGoogle Scholar
  68. 65.
    Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE (1994). Stable integration of retrovirally transduced genes into human umbilical cord blood high-proliferative potential colony forming cells (HPP-CFC) as assessed after multiple HPP-CFC colony replatings in vitro. Blood Cells 20:525–530.PubMedGoogle Scholar
  69. 66.
    Shi YJ, Shen RN, Lu L, Broxmeyer HE (1994). Comparative analysis of retroviral-mediated gene transduction into CD34+ cord blood hematopoietic progenitors in the presence and absence of growth factors. Blood Cells 20:517–524.PubMedGoogle Scholar
  70. 67.
    Hanley ME, Nolta JA, Parkman R, Kohn DB (1994). Umbilical cord blood cell transduction by retroviral vectors: pre-clinical studies to optimize gene transfer. Blood Cells 20:539–546.PubMedGoogle Scholar
  71. 68.
    Williams DA, Moritz T (1994). Umbilical cord blood stem cells as targets for genetic modification: new therapeutic approaches to somatic gene therapy. Blood Cells 20:504–516.PubMedGoogle Scholar
  72. 69.
    Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE (1994). Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:1867–1875.PubMedCrossRefGoogle Scholar
  73. 70.
    Broxmeyer HE, Cooper S, Etienne-Julan M, Wang XS, Ponnazhagan S, Braun S, Lu S, Srivastava A (in press). Cord blood transplantation and the potential for gene therapy: gene transduction using a recombinant adeno-associated viral vector. NY Acad Sci.Google Scholar
  74. 71.
    Li ZH, Broxmeyer HE, Lu L (1995). Cryopreserved cord blood myeloid progenitor cells can serve as targets for retroviral-mediated gene transduction and gene-transduced progenitors can be cryopreserved and recovered. Leukemia 9:S12-S16.PubMedGoogle Scholar
  75. 72.
    Lu L, Ge Y, Li ZH, Freie B, Clapp DW, Broxmeyer HE (1995). CD34+++ stem/progenitor cells purified from cryopreserved cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of fanconi anemia complement c gene. Cell Transpl 4:493–503.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1996

Authors and Affiliations

  • Hal E. Broxmeyer

There are no affiliations available

Personalised recommendations